参考文献/References:
[1]Razumilava N,Gores GJ.Cholangiocarcinoma.Lancet,2014,383(9935):2168-2179..
[2]Radtke A,Knigsrainer A.Surgical therapy of cholangiocarcinoma.Visc Med,2016,32(6):422-426.
[3]Zaydfudim VM,Clark CJ,Kendrick ML,et al.Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma.Am J Surg,2013,206(2):159-165.
[4]Chen W,Ke K,Chen YL.Combined portal vein resection in the treatment of hilar cholangiocarcinoma:a systematic review and metaanalysis.Eur J Surg Oncol,2014,40(5):489-495.
[5]Groeschl RT,Nagorney DM.Portal vein reconstruction during surgery for cholangiocarcinoma.Curr Opin Gastroenterol,2016,32(3):216-224.
[6]Matsuyama R,Mori R,Ota Y,et al.Significance of vascular resection and reconstruction in surgery for hilar cholangiocarcinoma:with special reference to hepatic arterial resection and reconstruction.Ann Surg Oncol,2016,23(Suppl 4):475-484.
[7]Hanog H,Ijzermans JN,van Gulik TM,et al.Resection of perihilar cholangiocarcinoma.Sung Clin North Am,2016,96(2):247-267.
[8]Morise Z,Wakabayashi G.First quarter century of laparoscopic liver resection.World J Gastroenterol,2017,23(20):3581-3588.
[9]Yoon YI,Kim KH,Kang SH,et al.Pure laparoscopic versus open right hepatectomy for hepatocellular carcinoma in patients with cirrhosis:a propensity score matched analysis.Ann Surg,2017,265(5):856-863.
[10]Cheung TT,Dai WC,Tsang SH,et al.Pure laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 110 patients with liver cirrhosis:a propensity analysis at a single center.Ann Surg,2016,264(4):612-620.
[11]陈德兴,曹春和,徐刚.腹腔镜上段胆管癌根治切除术.中国微创外科杂志,2008,8(1):31-34.
[12]朱安东,刘奇,陈德兴.腹腔镜下肝门部胆管癌根治术中淋巴结廓清方法的探讨.中国微创外科杂志,2010,10(10):922-924.
[13]Lee W,Han HS,Yoon YS,et al.Laparoscopic resection of hilar cholangiocarcinoma.Ann Surg Treat Res,2015,89(4):228-232.
[14]Gumbs AA,Jarufe N,Gayet B.Minimally invasive approaches to extrapancreatic cholangiocarcinoma.Surg Endosc,2013,27(2):406-414.
[15]Yu H,Wu SD,Chen DX,et al.Laparoscopic resection of Bismuth type I and II hilar cholangiocarcinoma:an audit of 14 cases from two institutions.Dig Surg,2011,28(1):44-49.
[16]Han IW,Jang JY,Kang MJ,et al.Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection.Ann Surg Treat Res,2014,87(2):87-93.
[17]Ebata T,Watanabe H,Ajioka Y,et al.Pathological appraisal of lines of resection for bile duct carcinoma.Brit J Surg,2002,89(10):1260-1267.
[18]梁廷波,白雪莉.肝门部胆管癌多学科团队的诊断与治疗.中华消化外科杂志,2015,14(4):268-274.